Article Details

Asthma Worsens with Repurposed Drug Licensed for Psoriasis

Retrieved on: 2021-10-29 13:13:35

Tags for this article:

Click the tags to see associated articles and topics

Asthma Worsens with Repurposed Drug Licensed for Psoriasis. View article details on hiswai:

Excerpt

The drug risankizumab, a humanized, monoclonal antibody, targets the proinflammatory cytokine IL-23. IL-23 inhibition has been an effective ...

Article found on: www.genengnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up